The role of dual oxidases in physiology and cancer

Abstract

NOX/DUOX enzymes are transmembrane proteins that carry electrons through biological membranes generating reactive oxygen species. The NOX family is composed of seven members, which are NOX1 to NOX5 and DUOX1 and 2. DUOX enzymes were initially called thyroid oxidases, based on their high expression level in the thyroid tissue. However, DUOX expression has been documented in several extrathyroid tissues, mostly at the apical membrane of the salivary glands, the airways, and the intestinal tract, revealing additional cellular functions associated with DUOX-related H₂O₂ generation. In this review, we will briefly summarize the current knowledge regarding DUOX structure and physiological functions, as well as their possible role in cancer biology.

Keywords
Dual oxidases; NADPH oxidases; reactive oxygen species; oxidative stress; cancer

Introduction

Reactive oxygen species (ROS) comprise a large group of radicals and non-radical molecules derived from molecular oxygen (O₂). Radical molecules, such as superoxide (O₂ ^•-) and hydroxyl (OH•), have an unpaired electron in their outer shell, which is not the case with non-radical ROS, such as hydrogen peroxide (H₂O₂). Generally, the initial step of ROS formation is the transfer of one electron to O₂ forming O₂ ^•- that can then be converted to H₂O₂ spontaneously or by the activity of the superoxide dismutase enzyme (Halliwell and Gutteridge, 2015). ROS availability depends on the rate of its production, as well as its detoxification by antioxidants mechanisms. The imbalance between oxidants and antioxidants in favor of the oxidants, leading to a disrup tion of redox signaling and control and/or molecular damage, is called oxidative stress (Sies and Jones, 2007).

ROS can interact with a broad spectrum of substances, including small inorganic molecules, proteins, lipids, and nucleic acids, altering their structures either reversibly or not. Decades ago several authors classified ROS as harmful to biological organisms, being extensively related to diseases and aging (Liochev, 2013). However, this was reconsidered, assuming that they are also important in cellular signaling through reversible regulatory mechanisms involved in the physiology of virtually all tissues (Brigeluis-Flohé, 2009s).

Endogenous and exogenous factors can influence ROS production through enzymatic or non-enzymatic reactions. In mitochondria, O₂ is partially reduced to O₂ ^•- due to the leakage of electrons from mitochondrial protein complexes during oxidative phosphorylation (Liu et al., 2002). The cytochrome P450 family is composed of heme-enzymes that play a critical role in the metabolism of drugs and other xenobiotics, producing ROS as a by-product of their main reaction (Meunier et al., 2004). Xanthine oxidase is a flavoenzyme involved in the hydroxylation of purines and aldehydes, although its main function is to catalyze the conversion of hypoxanthine to xanthine and xanthine to uric acid. Xanthine oxidase delivers electrons directly to O , thus generating O₂ ^•- and H₂O₂, via a one-electron and a two-electron reduction, respectively (Sabán-Ruiz et al., 2013). It is important to note that all ROS sources described above produce them as a by-product of their main reactions, which is not the case with NADPH oxidases (NOX) that have ROS generation as their main function.

NADPH oxidases

NOX enzymes are transmembrane proteins that carry electrons across biological membranes, reducing O₂ to O₂ ^•- or H₂O₂. The NOX family is composed of seven members, which are NOX1 to NOX5 and DUOX1 and 2. All NOX isoforms have six highly conserved transmembrane domains, one NADPH binding site in the C-terminal region, one FAD binding site, and two histidine-linked heme groups in the transmembrane domains III and IV. Unlike the isoforms 1-4, NOX5 and DUOX 1 and 2 have an intracellular calcium-binding site that is closely related to their activation (Drummond et al., 2011). Most NOX isoforms require at least one cytosolic or membrane-bound binding partner for their maturation, stabilization, heme incorporation, and correct trafficking to their physiological site (Opitz et al., 2007). p22phox is a stabilizing membrane protein that associates to NOX1–4 at biological membranes. p67phox and p40phox are crucial for NOX2 activation, as well as its analog NOXA1 is for NOX1. p47phox stabilizes the complex formation for NOX2. NOXO1 enables the active complex formation for NOX1 and NOX3. DUOX1 and 2 associate to DUOXA1 and DUOXA2, respectively, which are involved in their trafficking to the plasma membrane and activity (Grasberger and Refetoff, 2006). Finally, NOX1-3 needs the small GTPase Rac for their activity, but its importance for NOX3 activity is still controversial (Ueno et al., 2005; Ueyama et al., 2006). Interestingly, NOX4 appears to be constitutively active, but some binding proteins, such as p22phox and poldip2, are able to increase its basal activity (Lyle et al., 2009).

ROS generation by NOX enzymes occurs due to the transfer of two electrons from NAPDH via their FAD domain and two iron-heme prosthetic groups to O₂ (Altenhöfer et al., 2015). In fact, an electron is transferred from NADPH to FAD, reducing it to FADH₂, followed by a subsequent electron transfer from FADH₂ to the iron atom of the first heme group. Oxygen binds to the second heme of the NOX structure and receives an electron from the first heme. This monoelectronic transfer to O₂ reduces it to O₂ ^•-. However, several studies suggest that the final product of NOX4, DUOX1, and DUOX2 is H₂O₂ (Drummond et al., 2011). As the transfer of two electrons from a heme group to O₂ is thermodynamically not favorable, it is believed that H₂O₂ is produced due to a rapid dismutation of O₂ ^•- and/or through the interaction of O₂ ^•- with histidines present in the third extra-cellular loop of NOX (Block et al., 2012; Takac et al., 2012).

NOX enzymes are found in distinct subcellular locations, which may vary according to cell type. All NOX isoforms have already been described in the plasma membrane, generating ROS for the extracellular medium. In addition, the presence of NOX1 was described in endosomes. NOX2, NOX4, and NOX5 were also found in the endoplasmic reticulum (Chen et al., 2008; Lassègue et al., 2010). Moreover, NOX4 was also found in mitochondria, and in the perinuclear membrane (Graham et al., 2010). Interestingly, NOX enzymes can also be located in specific cellular microdomains, such as focal adhesions (NOX4) and lipid rafts (NOX1). It was also observed that both NOX1 and NOX4 are found in invadopodia, which are plasma membrane protrusions formed during the tumor invasion process where adhesion proteins and various proteases accumulate (Berdard and Krause, 2007; Lassègue and Griendling, 2010).

The role of NOXs in human physiology and pathophysiology has been progressively elucidated. It has been shown that NOX-derived ROS can modulate a wide range of cellular signaling pathways and transcription factors. Furthermore, NOX activity is involved in thyroid hormone biosynthesis, growth regulation, and cell senescence, among other mechanisms (Bedard and Krause, 2007). Here we will focus on the physiological functions of DUOX enzymes, as well as their possible role in various types of cancers.

Dual oxidases

The DUOX1 and DUOX2 genes, previously called THOX1 and THOX2, respectively, were cloned for the first time from human and porcine thyroid gland tissue (Dupuy et al., 1999; De Deken et al., 2000). The DUOX2 gene is located on chromosome 15, in 15q15.3-q21.1. It generates an mRNA of 6532 nucleotides, encoding a protein of 1548 amino acids. The DUOX1 gene is at the same locus as DUOX2, and it encodes a protein of 1551 amino acids, which shares with DUOX2 more than 77% sequence identity at the amino acid level (Carvalho and Dupuy, 2017). Both DUOXs have seven transmembrane domains, with two calcium-binding sites in its large intracellular loop, which are located between the first two transmembrane segments. Moreover, they also have an N-terminal extracellular domain called the peroxidase homology domain, due to its 43% similarity with thyroperoxidase (TPO) (Dupuy et al., 1999; De Deken et al., 2000) (Figure 1). While peroxidase activity of DUOX in mammalian cells was never experimentally demonstrated, this has been shown in the nematode Caenorhabditis elegans (Grasberger et al., 2007; Meitzler et al., 2009; Morand et al., 2009). Interestingly, we and others have demonstrated that the peroxidase homology domain is crucial for the interaction of DUOX with TPO and DUOXA, as well as for DUOX intrinsic activity (Fortunato et al., 2010; Song et al., 2010; Carré et al., 2015, Louzada et al., 2018).

Figure 1
Schematic structures of DUOX and DUOXA proteins. DUOX enzymes have seven transmembrane domains, with two calcium-binding sites in its large intracellular loop. They also have an N-terminal extracellular domain called the peroxidase homology domain, due to its similarity with thyroperoxidase. DUOX activator protein (DUOXA), DUOXA1 and DUOXA2, are necessary to ER-to-Golgi transition and targeting of DUOXs to the plasma membrane. DUOXA is co-localized with DUOX at the plasma membrane, and this association is crucial to DUOX activity. DUOX, Dual oxidase; DUOXA, DUOX activator protein. The figure was created using Adobe Illustrator CC.

DUOX enzymes are transmembrane proteins, and they are fully active only at the apical plasma membrane. DUOX2 maturation steps are its ectodomain N-linked glycosylation in the endoplasmic reticulum and the redesigning of sugar motifs in the Golgi apparatus. Furthermore, the DUOX activator proteins (DUOXA), DUOXA1 and DUOXA2, are necessary for ER-to-Golgi transition and the targeting of DUOXs to the plasma membrane (Grasberger and Refetoff, 2006). DUOXA is co-localized with DUOX at the plasma membrane, and this association is crucial for the H₂O₂-generating system (Ameziane-El-Hassani et al., 2005; Morand et al., 2009). DUOXA knockout led to an impaired DUOX targeting to the plasma membrane and lack of H₂O₂ production in the thyroid, resulting in severe goitrous congenital hypothyroidism (Zamproni et al., 2008). Calcium is the main activator of DUOX1 and DUOX2 activities, acting through the two EF-hand Ca2+-binding motifs (Ameziane-El-Hassani et al., 2005). In a heterologous system, DUOX1 and DUOX2 activities were increased by protein kinase A (PKA) and protein kinase A (PKC), respectively (Rigutto et al., 2009). Moreover, at least in the thyroid, iodide plays a dual role in the control of DUOX activity, being stimulatory at low concentrations and inhibitory at high concentrations (Corvilain et al., 2000; Cardoso et al., 2001; Morand et al., 2003).

Physiological roles of DUOXs

DUOX enzymes were initially called thyroid oxidases (THOX), based on their high expression level in the thyroid tissue (Dupuy et al., 1999; De Deken et al., 2000). However, DUOX expression has since been documented in several extrathyroid tissues, mostly at the apical cell membrane of the salivary glands, the airways, and the intestinal tract, revealing additional cellular functions associated with DUOX-related H₂O₂ generation (Geiszt et al., 2003). Physiological functions of DUOXs are shown in Table 1 according to their cell type specificity in mammals.

Table 1
DUOXs physiological functions in mammals according to cell-type specificity.

Cell type	DUOX isoform	Physiological Function	References
Thyrocyte	DUOX2	TH biosynthesis	Dupuy et al. 1999; De Deken et al., 2000; Johnson et al., 2007; Grasberger, 2010.
Mucosal surfaces (salivary glands, rectum, trachea, bronchium)	DUOX1/DUOX2	Antimicrobial activity	Geiszt et al., 2003; El-Hassani et al., 2005.
Airway epithelium	DUOX1/	Wound response Inflammation	Schwarzer et al., 2004.
	DUOX2		Wesley et al., 2007; Cho et al., 2013; Gorissen et al., 2013; Sham et al., 2013; de Oliveira et al., 2015; Hristova et al., 2016;
Urothelial	DUOX1	Host defense	Donkó et al., 2010.
Immune cell	DUOX1	Polarization	Singh et al., 2005; Kwon et al., 2010.

The thyroid gland is responsible for synthesizing, storing, and secreting thyroid hormones (TH): thyroxine and triiodothyronine. TH biosynthesis occurs at the interface of the apical thyroid cell plasma membrane and the colloid, where thyroperoxidase (TPO) and DUOXs are co-localized (Fortunato et al., 2010; Song et al., 2010) (Figure 2). TPO catalyzes the three steps of TH biosynthesis, and its activity depends on H₂O₂ , which is an essential cofactor for its catalytic activity (Carvalho and Dupuy, 2017). Two genes encode the thyroid H₂O₂-generating system, DUOX1 and DUOX2 (Dupuy et al., 1999; De Deken et al., 2000). Nowadays, it is well established that DUOX2 is the NOX isoform that sustains TH production, since mutations in Duox2, but not in Duox1, are associated with congenital hypothyroidism in mice, and mice deficient in Duox2, but not Duox1, are hypothyroid (Johnson et al., 2007; Grasberger, 2010). However, DUOX1 seems to be able to compensate DUOX2 activity, since patients with complete inactivation of both alleles of DUOX2 presented partial and transient hypothyroidism (Maruo et al., 2008; Hoste et al., 2010). Intriguingly, the physiological role of DUOX1 in the thyroid gland remains to be elucidated.

Figure 2
Schematic representation of thyroid hormones biosynthesis at the apical membrane of thyrocytes. The inorganic iodide from the diet is actively transported by the sodium iodide symporter (NIS) through the basolateral plasma membrane of follicular cells. After that, iodide is translocated from the cytoplasm across the apical plasma membrane into the follicular lumen through pendrin (PDS). At the interface of the apical thyroid cell plasma membrane and the colloid, thyroperoxidase (TPO) catalyzes the three steps of HT biosynthesis, and its activity depends on the presence of hydrogen peroxide (H₂O₂), which is an essential cofactor for its catalytic activity, being generated by the enzyme dual oxidase 2 (DUOX2), which is also located at the apical membrane of thyrocytes. DUOXA2 is crucial to ER-to-Golgi transition and targeting of DUOXs to the plasma membrane.

The presence of DUOX enzymes in secretory glands and on mucosal surfaces, such as salivary gland, rectum, trachea, and bronchium led to their identification as a source of H₂O₂, supporting lactoperoxidase (LPO)-catalyzed oxidation of thiocyanate (SCN-) or iodide (I-) to form secondary oxidants, like hypothiocyanous acid (HOSCH) and hypoiodous acid (HOI) with significant antimicrobial activity (Geiszt et al., 2003; El-Hassani et al., 2005).

In airway epithelial cells, DUOX1 was demonstrated to be the main NOX isoform, producing extracellular H₂O₂ in response to ATP, histamine, LPS, and flagellin (Forteza et al., 2005; Boots et al., 2009; Rada and Leto, 2010; Rada et al., 2013). In fact, the activation of DUOX1 by damage-associated molecular signals, such as the purine metabolite ATP suggests a potential role of this enzyme in epithelial wound responses, once studies performed in cultured epithelial airway cells showed an increased expression of several wound response genes, such as MMP-9 and IL-8, and cell migration (Wesley et al., 2007; Sham et al., 2013). Similarly, in an in vivo model of mice lung epithelial injury, the involvement of DUOX1 in wound response was reported (Gorissen et al., 2013). Sequential works pointed to the capacity of epithelial DUOX1 in inducing the production of cytokines and chemokines, as well as neutrophil recruitment (Cho et al., 2013; de Oliveira et al., 2015). More recent studies also revealed the involvement of DUOX1 in the secretion of the alarmin IL-33 by airway epithelia in response to injurious stimuli, an important integrant of type 2 immunity, mediated by activation of the non-receptor tyrosine kinase Src and EGF receptor (Hristova et al., 2016). In addition, DUOX1-dependent ROS were demonstrated to stimulate TNF-α synthesis and secretion, with consequent mucin production, suggesting DUOX1 as a putative target for therapies in cases of chronic inflammatory airway diseases associated with mucus hypersecretion (Schwarzer et al., 2004.)

DUOX1 was shown to be expressed in urothelial cells, acting in host defense in the bladder (Donkó et al., 2010). Importantly, cumulative evidence has pointed to the presence of DUOX1 in lymphocytes T and B, acting in T or B-cell receptor signaling, and also in macrophages and innate lymphoid cells, related to polarization processes (Singh et al., 2005; Kwon et al., 2010). Collectively, even in the face of a not very robust body of evidence, DUOX1 seems to have a marked role in host defense and related signaling.

According to a proteomic screen, these innumerous actions of DUOX1 are related to H₂O₂-dependent regulation of redox-sensitive cell signaling pathways, specifically through cysteine oxidation within several cellular targets, such as cytoskeletal proteins, oxidoreductase enzymes, and proteins linked to cell metabolism. Tyrosine kinases signaling seem to be the most impacted pathway, either by direct oxidation of tyrosine kinases, and/or inactivation of protein phosphatases (Hristova et al., 2014).

DUOX enzymes have homologs related to cell differentiation, development and host defense reported in many multicellular non-mammalian organisms (Table 2) (Kawahara et al., 2007). In the sea urchin egg, a calcium-dependent respiratory burst at fertilization, attributed to a Dual oxidase called Udx1, is responsible to support ovoperoxidase activity, which blocks polyspermy through crosslinking of the fertilization envelope (Wong et al., 2004). Ce-Duox1 (or BLI-3) was detected in the hypodermis of Caenorhabditis elegans, where seems to be involved in the stabilization of the cuticular extracellular matrix through oxidative crosslinking of tyrosine residues (Edens et al., 2001). Furthermore, host defense functions were described for DUOX homologs in Drosophila melanogaster, zebrafish, and also C. elegans, and attributed to their ability to activate p38 MAPK signaling and Nrf-2, thereby enhancing resistance to invading pathogens (Flores et al., 2010; Anh et al., 2011; van der Hoeven et al., 2011).

Table 2
Physiological functions of DUOXS in non-mammalians.

Organism	DUOX	Function	References
	Homologue
Sea urchin egg	Udx1	Fertilization	Wong et al., 2004
Caenorhabditis elegans	BLI-3 (Duox1)	Stabilization of the cuticular extracellular matrix	Edens et al., 2001
		Host defense	van der Hoeven et al., 2011
Drosophila melanogaster	dDuox	Host defense	Anh et al., 2011
Zebrafish	Duox	Host defense	Flores et al., 2010

DUOXs and cancer

Carcinogenesis involves a sequence of cellular and molecular events that promote the transformation of a normal cell into a cancer cell, such as a permanent stimulus for proliferation, evasion of mitotic control, cell death resistance, replicative immortality, evasion of immune surveillance, activation of invasion and metastasis, angiogenesis, genetic instability, and metabolic deregulation. This process can be divided into three stages: initiation, promotion, and progression, and it is well established that ROS may influence the underlying molecular mechanisms involved in all these stages (Hanahan and Weinberg, 2011). Cancer cells usually produce high levels of ROS in a wide range of tumor types, and this can be attributed, at least in part, to the upregulation of NOX enzymes (Roy et al., 2015). There are several reports demonstrating the role of NOX1-5 in the tumorigenesis of various tissues, but little is known about the DUOXs.

As stated above, thyroid cells produce large amounts of H₂O₂ during thyroid hormone biosynthesis, whose source is the DUOX2 enzyme. Thyroid has a spontaneous mutation rate that is about eight times higher than in the liver, which is a highly metabolic organ. As 8-oxoguanine, a marker of DNA oxidation, was also higher in the thyroid when compared to other organs, it was suggested that DUOX-derived H₂O₂ could be involved in this process (Maier et al., 2006). Previous studies evaluated DUOX expression and activity in samples of thyroid carcinomas, but no significant differences in the activity or expression of these enzymes were detected between normal and cancerous tissues (Caillou et al., 2001; Lacroix et al., 2001; Ginabreda et al., 2008). Human thyroid cell line and primary thyrocytes exposed to ionizing radiation (IR) had their DUOX1 expression and activity increased, which was probably mediated by IL-13. Interestingly, the DUOX1 increase was maintained several days after the insult and was associated with DNA damage and growth arrest. Moreover, higher DUOX1 expression was found in human radio-induced thyroid tumors, as well as in sporadic thyroid tumors (Ameziane-El-Hassani et al., 2015). However, no differences in DUOX1 expression were found in sporadic papillary thyroid carcinoma that occurs in the absence of previous radiation exposure and in radiation-induced papillary thyroid carcinoma from the Chernobyl Tissue Bank (Detours et al., 2007; Dom et al., 2012).

DUOX1 expression was found to be lower in liver cancer tissues and liver cancer cell lines in comparison to non-tumor tissues and immortalized non-tumor cell lines (Ling et al., 2014; Chen et al., 2016; Eun et al., 2017). DUOX1 promoter methylation was detected in primary hepatocellular carcinoma (HCC), but not in non-tumor tissues. In the HCC cell line SMMC-7721, 5-aza-2’-deoxycytidine treatment reversed DUOX1 silencing and decreased cell proliferation and colony formation ability through the induction of G2/M phase cell cycle arrest (Ling et al., 2014). Moreover, DUOX1 expression was associated with genes that inhibit tumor progression (Eun et al., 2017), and patients with high DUOX1 expression presented longer disease-free survival and overall survival compared with those with low expression of DUOX1, suggesting that DUOX1 expression could be a potential prognostic tool for patients with liver tumors (Chenet al., 2016; Eun et al., 2017). However, Lu et al. (2011) found higher DUOX1 and DUOX2 expression in HCC in comparison to non-cirrhotic normal liver tissues, which were related to poorer recurrence-free survival and overall survival (Lu et al., (2011)). In HCC cell lines, DUOX2 expression and activity seem to be positively regulated by protein kinase C alpha (PKCα), which is overexpressed in HCC and is implicated in malignant transformation through enhancing multiple cellular signaling pathways. Silencing of DUOX2 abrogated PKCα-induced ROS generation, as well as AKT/MAPK activation and cell proliferation, migration, and invasion, suggesting that the interplay between PKCα and DUOX2 can be involved in HCC development (Wang et al., 2015).

Lung cancer also presents decreased expression of DUOX1 and DUOX2 that is correlated with hypermethylation of CpG-rich promoter regions of DUOX genes. Moreover, DUOXA1 and DUOXA2 were down-regulated in lung cancer cells and lung cancer tissues (Luxen et al., 2008). The loss of DUOX1 in lung cancer cell lines was associated to decreased E-cadherin (an epithelial marker), and RNAi-mediated DUOX1 silencing induced epithelial-to- mesenchymal transition (EMT), which is closely related to metastasis (Little et al., 2016). The reintroduction of functional DUOX1 into lung cancer cell lines increased cell migration and wound repair and decreased EMT, but no differences were found in cell proliferation (Luxen et al., 2008; Little et al., 2016). In accordance with EMT induction, silencing DUOX1 in H292 cells induced epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor resistance, enhanced EMT-like CD24^low/CD44^high cell populations, increased cancer stem cell markers, and was responsible for an invasive phenotype, which was demonstrated by in vitro and in vivo assays (Little et al., 2016). Interestingly, the lack of DUOX1 promoted EGF-induced EGFR internalization and nuclear localization, which was associated with induction of EGFR-regulated genes and related tumorigenic outcomes. DUOX1-deficient cells had an overall reduction in EGFR cysteines that was mediated by the enzyme glutathione S-transferase P1 (Little et al., 2019). Thus, the loss of DUOX1 found in lung epithelial cancer cells seems to be strongly associated with an invasive and metastatic phenotype.

It is well known that pancreatic inflammation accelerates the development and progression of pancreatic cancer, which is, at least in part, mediated by ROS. DUOX2 seems to be involved in this process, once INF-γ increases its expression and activity through the activation of the Jak-Stat1 and p38-MAPK pathway in human pancreatic cancer cell lines (Wu et al., 2011). Interestingly, VEGF-A and HIF-1α transcription were increased by INF-γ through ERK signaling activation after INF-γ that was abolished by concomitant treatment with a NOX inhibitor and by DUOX2 knockdown (Wu et al., 2016). Furthermore, concomitant treatment of a pancreatic cancer cell line with INF-γ and LPS increased DUOX2 expression and activity through TLR4-NF-κB activation, which decreased cell proliferation, and increased apoptosis and DNA damage. These results are in agreement with the increased levels of DUOX found in pancreatic cancer xenografts, chronic pancreatitis, and human pancreatic cancers (Wu et al., 2013a,b, 2016). Besides, it was shown that DUOX2 mRNA and protein levels were increased in gastric and colorectal cancers (CRC) compared to the adjacent nonmalignant tissues (Qi et al., 2016). The high levels of DUOX2 in gastric cancer were significantly associated with smoking history, while its protein expression levels in CRC were higher in stages II-IV than in stage I (Qi et al., 2016). However, the results are conflicting with regard to DUOX2 and CRC. Cho et al. (2018) showed that DUOX2 expression was higher in CRC, which was associated to a better prognosis (Cho et al., 2018). Furthermore, a study by You et al. (2018) analyzed three cancer databases and found lower DUOX1/2 mRNA levels in gastric cancer that were correlated to better overall survival (You et al., 2018)

DUOX enzymes were also found to be involved in mechanisms related to drug resistance in some tumor types. In the prostate cancer cell line PC3, the inhibition of DUOX enzymes by NOX inhibitor, intracellular calcium chelation and small-interfering RNA (siRNA) resulted in decreased AKT signaling and decreased resistance to apoptosis. In this cell line, H₂O₂ produced by DUOX was responsible for inactivating protein phosphatases, which maintained the phosphorylation of AKT and glycogen synthase kinase 3β (Pettigrew et al., 2013). Kang et al. (2018) showed that DUOX2-derived H₂O₂ mediates 5-Fluorouracil (FU)-resistance in colon cancer cells. 5-FU–resistant SNUC5 colon cancer cells had higher levels of EMT markers, as well as higher DUOX2 mRNA levels and activity. Moreover, the antioxidant N-acetylcysteine attenuated the effects of 5-FU on EMT and metastasis, suggesting the involvement of DUOX2-derived H₂O₂ (Kang et al., 2018).

Recently, we demonstrated that DUOX1, but not DUOX2, is downregulated in breast cancer cell lines and breast cancer tissues. In order to show the physiological consequences of DUOX1 loss, we silenced DUOX1 in a non-tumor human mammary epithelial cell line MCF12A. DUOX1 silencing was responsible for increasing cell proliferation and decreasing cell adhesion and migration, but no differences were found in invasion capacity. After doxorubicin-induced genotoxic stress, MCF12A cells had their extracellular H₂O₂ production increased, as well as their IL-6 and IL-8 secretion, which were abolished in DUOX1-silenced cells. Moreover, DUOX1-silenced cells continued to proliferate after genotoxic stress. Taken together, these data suggest that DUOX1 is involved in genotoxic stress response in mammary cells, and its downregulation in breast cancer could be related to chemotherapy response (Fortunato et al., 2018).

Concluding remarks

Herein, we present an overview of physiological roles associated with DUOX enzymes and their role in cancer biology. Despite their known role in processes such as thyroid hormonogenesis, host defense, and immunoregulation, evidence suggests that dysregulation of DUOX1/DUOX2 signaling is involved in the carcinogenic process. Future studies are necessary to clarify the involvement of DUOXs in cancer-related signaling pathways. Elucidating this issue is crucial for improving our knowledge of the mechanisms involved in carcinogenesis and will allow us to determine whether DUOXs can be potential therapeutic targets for cancer treatment.

Acknowledgments

We thank the following Brazilian agencies for financial support: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), and Coordenação de Aperfeiçoamento de Pessoal de Nível superior (CAPES – Brasil, Finance Code 001).

References

• Altenhöfer S, Radermacher KA, Kleikers PW, Wingler K and Schmidt HH (2015) Evolution of NADPH oxidase inhibitors: Selectivity and mechanisms for target engagement. Antiox Redox Signal 23:406-427.
• Ameziane-El-Hassani R, Morand S, Boucher JL, Frapart YM, Apostolou D, Agnandji D, Gnidehou S, Ohayon R, Noel-Hudson MS, Francon J et al. (2005) Dual oxidase-2 has an intrinsic Ca2 + -dependent H₂O₂-generating activity. J Biol Chem 280:30046–30054.
• Ameziane-El-Hassani R, Talbot M, de Souza Dos Santos MC, Al Ghuzlan A, Hartl D, Bidart JM, De Deken X, Miot F, Diallo I, de Vathaire F et al. (2015) NADPH oxidase DUOX1 promotes long-term persistence of oxidative stress after an exposure to irradiation. Proc Natl Acad SciUSA 112:5051-5056.
• Anh NTT, Nishitani M, Harada S, Yamaguchi M and Kamei K (2011) Essential role of Duox in stabilization of Drosophila wing. J Biol Chem 286:33244–33251.
• Bedard K and Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 87:245–313.
• Block K and Gorin Y (2012) Aiding and abetting roles of NOX oxidases in cellular transformation. Nat Rev Cancer 12:627–637. Brigelius-Flohé R (2009) Commentary: Oxidative stress reconsidered. Genes Nutr 4:161–163.
• Boots AW, Hristova M, Kasahara DI, Haenen GRMM, Bast A and van der Vliet A (2009) ATP-mediated activation of the NADPH oxidase DUOX1 mediates airway epithelial responses to bacterial stimuli. J Biol Chem 284:17858–17867.
• Caillou B, Dupuy C, Lacroix L, Nocera M, Talbot M, Ohayon R, Dème D, Bidart JM, Schlumberger M and Virion A (2001) Expression of reduced nicotinamide adenine dinucleotide phosphate oxidase (ThoX, LNOX, Duox) genes and proteins in human thyroid tissues. J Clin Endocrinol Metab 86:3351-3358.
• Cardoso LC, Martins DC, Figueiredo MD, Rosenthal D, Vaisman M, Violante AH and Carvalho DP (2001) Ca2+/nicotinamide adenine dinucleotide phosphate-dependent H₂O₂ generation is inhibited by iodide in human thyroids. J Clin Endocrinol Metab 86:4339–4343.
• Carré A, Louzada RA, Fortunato RS, Ameziane-El-Hassani R, Morand S, Ogryzko V, de Carvalho DP, Grasberger H, Leto TL and Dupuy C (2015) When an intramolecular disulfide bridge governs the interaction of DUOX2 with its partner DUOXA2. Antioxid Redox Signal 23:724-733.
• Carvalho DP and Dupuy C (2017) Thyroid hormone biosynthesis and release. Mol Cell Endocrinol 458:6-15.
• Chen S, Ling Q, Yu K, Huang C, Li N, Zheng J, Bao S, Cheng Q, Zhu M and Chen M (2016) Dual oxidase 1: A predictive tool for the prognosis of hepatocellular carcinoma patients. Oncol Rep 35:3198-208.
• Chen K, Kirber MT, Xiao H, Yang Y and Keaney JF Jr. (2008) Regulation of ROS signal transduction by NADPH oxidase 4 localization. J Cell Biol 181:1129-1139.
• Cho DY, Nayak JV, Bravo DT, Le W, Nguyen A, Edward JA, Hwang PH, Illek B and Fischer H (2013) Expression of dual oxidases and secreted cytokines in chronic rhinosinusitis. Int Forum Allergy Rhinol 3:376–383.
• Cho SY, Kim JS, Eun HS, Kang SH, Lee ES, Kim SH, Sung JK, Lee BS, Jeong HY and Moon HS (2018) Expression of NOX family genes and their clinical significance in colorectal cancer. Dig Dis Sci 63:2332-2340.
• Corvilain B, Collyn L, van Sande J and Dumont JE (2000) Stimulation by iodide of H₂O₂ generation in thyroid slices from several species. Am J Physiol Endocrinol Metab 278:E692–E699.
• Detours V, Delys L, Libert F, Weiss Solís D, Bogdanova T, Dumont JE, Franc B, Thomas G and Maenhaut C (2007) Genome-wide gene expression profiling suggests distinct radiation susceptibilities in sporadic and post-Chernobyl papillary thyroid cancers. Br J Cancer 97:818-825.
• De Deken X, Wang D, Many MC, Costagliola S, Libert F, Vassart G, Dumont JE and Miot F (2000) Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 275:23227–23233.
• de Oliveira S, Boudinot P, Calado  and Mulero V (2015) Duox1-derived H₂O₂ modulates Cxcl8 expression and neutrophil recruitment via JNK/c-JUN/AP-1 signaling and chromatin modifications. J Immunol 194:1523–1533.
• Dom G, Tarabichi M, Unger K, Thomas G, Oczko-Wojciechowska M, Bogdanova T, Jarzab B, Dumont JE, Detours V and Maenhaut C (2012) A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas. Br J Cancer 107:994-1000.
• Donkó A, Ruisanchez E, Orient A, Enyedi B, Kapui R, Péterfi Z, de Deken X, Benyó Z and Geiszt M (2010) Urothelial cells produce hydrogen peroxide through the activation of Duox1. Free Radic Biol Med 49:2040–2048.
• Drummond GR, Selemidis S, Griendling KK and Sobey CG (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10:453-471.
• Dupuy C, Ohayon R, Valent A, Noël-Hudson MS, Dème D and Virion A (1999) Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cDNAs. J Biol Chem 274:37265e37269.
• Edens WA, Sharling L, Cheng G, Shapira R, Kinkade JM, Lee T, Edens HA, Tang X, Sullards C, Flaherty DB et al. (2001) Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J Cell Biol 154:879–891.
• El Hassani RA, Benfares N, Caillou B, Talbot M, Sabourin JC, Belotte V, Morand S, Gnidehou S, Agnandji D, Ohayon R et al. (2005) Dual oxidase2 is expressed all along the digestive tract. Am J Physiol Gastrointest Liver Physiol 288:G933-G942.
• Eun HS, Cho SY, Joo JS, Kang SH, Moon HS, Lee ES, Kim SH and Lee BS (2017) Gene expression of NOX family members and their clinical significance in hepatocellular carcinoma. Sci Rep 7:11060.
• Flores MV, Crawford KC, Pullin LM, Hall CJ, Crosier KE and Crosier PS (2010) Dual oxidase in the intestinal epithelium of zebrafish larvae has anti-bacterial properties. Biochem Biophys Res Commun 400:164–168.
• Forteza R, Salathe M, Miot F, Forteza R and Conner GE (2005). Regulated hydrogen peroxide production by Duox in human airway epithelial cells. Am J Respir Cell Mol Biol 32:462–469.
• Fortunato RS, Lima de Souza EC, Ameziane-el Hassani R, Boufraqech M, Weyemi U, Talbot M, Lagente-Chevallier O, de Carvalho DP, Bidart JM, Schlumberger M et al. (2010) Functional consequences of dual oxidase-thyroperoxidase interaction at the plasma membrane. J Clin Endocrinol Metab 95:5403-5411.
• Fortunato RS, Gomes LR, Munford V, Pessoa CF, Quinet A, Hecht F, Kajitani GS, Milito CB, Carvalho DP and Menck CFM (2018) DUOX1 Silencing in mammary cell alters the response to genotoxic stress. Oxid Med Cell Longev 2018:3570526.
• Geiszt M, Witta J, Baffi J, Lekstrom K and Leto TL (2003) Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J 17:1502–1504.
• Ginabreda MG, Cardoso LC, Nobrega FM, Ferreira AC, Gonçalves MD, Vaisman M and Carvalho DP (2008) Negative correlation between thyroperoxidase and dual oxidase H₂O₂-generating activities in thyroid nodular lesions. Eur J Endocrinol 158:223-227.
• Gorissen SH, Hristova M, Habibovic A, Sipsey LM, Spiess PC, Janssen-Heininger YM and van der Vliet A (2013) Dual Oxidase–1 is required for airway epithelial cell migration and bronchiolar reepithelialization after injury. Am J Respir Cell Mol Biol 48:337–345.
• Graham KA, Kulawiec M, Owens KM, Li X, Desouki MM, Chandra D and Singh KK (2010) NADPH oxidase 4 is an onco-protein localized to mitochondria. Cancer Biol Ther 10:223-231.
• Grasberger H (2010) Defects of thyroidal hydrogen peroxide generation in congenital hypothyroidism. Mol Cell Endocrinol 322:99–106.
• Grasberger H and Refetoff S (2006) Identification of the maturation factor for dual oxidase. Evolution of an eukaryotic operon equivalent. J Biol Chem 281:18269e18272.
• Grasberger H, De Deken X, Miot F, Pohlenz J and Refetoff S (2007) Missense mutations of dual oxidase 2 (DUOX2) implicated in con-genital hypothyroidism have impaired trafficking in cells reconsti-tuted with DUOX2 maturation factor. Mol Endocrinol 21:1408–142121.
• Halliwell B and Gutteridge J (2015) Free radicals in biology and medicine. 5th edition. Oxford University Press, Oxford.
• Hanahan D and Weinberg RA (2011) Hallmarks of cancer: The next generation. Cell 144:646–674.
• Hoeven Rv, McCallum KC, Cruz MR and Garsin DA (2011) Ce-Duox1/BLI-3 generated reactive oxygen species trigger protective SKN-1 activity via p38 MAPK signaling during infection in C. elegans. PLoS Pathog 7:e1002453.
• Hoste C, Rigutto S, Van Vliet G, Miot F and De Deken X (2010) Compound heterozygosity for a novel hemizygous missense mutation and a partial deletion affecting the catalytic core of the H(2)O(2)-generating enzyme DUOX2 associated with transient congenital hypothyroidism. Hum Mutat 31:E1304eE1319.
• Hristova M, Veith C, Habibovic A, Lam YW, Deng B, Geiszt M, Janssen-Heininger YM and van der Vliet A (2014) Identification of DUOX1-dependent redox signaling through protein S-glutathionylation in airway epithelial cells. Redox Biol 2:436–446.
• Hristova M, Habibovic A, Veith C, Janssen-Heininger YM, Dixon AE, Geiszt M and van der Vliet A (2016). Airway epithelial dual oxidase 1 mediates allergen-induced IL-33 secretion and activation of type 2 immune responses. J Allergy Clin Immunol 137:1545–1556.e11.
• Johnson KR, Marden CC, Ward-Bailey P, Gagnon LH, Bronson RT and Donahue LR (2007) Congenital hypothyroidism, dwarfism, and hearing impairment caused by a missense mutation in the mouse dual oxidase2 gene, Duox2. Mol Endocrinol 21:1593–1602.
• Kang KA, Ryu YS, Piao MJ, Shilnikova K, Kang HK, Yi JM, Boulanger M, Paolillo R, Bossis G, Yoon SY et al. (2018) DUOX2-mediated production of reactive oxygen species induces epithelial mesenchymal transition in 5-fluorouracil resistant human colon cancer cells. Redox Biol 17:224-235.
• Kawahara BT, Quinn MT and Lambeth JD (2007) Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes. BMC Evol Biol 7:109.
• Kwon J, Shatynski KE, Chen H, Morand S, de Deken X, Miot F, Leto TL and Williams MS (2010) The Nonphagocytic NADPH oxidase Duox1 mediates a positive feedback loop during T cell receptor signaling. Sci Signal 3:ra59.
• Lacroix L, Nocera M, Mian C, Caillou B, Virion A, Dupuy C, Filetti S, Bidart JM and Schlumberger M (2001) Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas. Thyroid 11:1017-1023.
• Lassègue B and Griendling KK (2010) NADPH oxidases: Functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 30:653–661.
• Ling Q, Shi W, Huang C, Zheng J, Cheng Q, Yu K, Chen S, Zhang H, Li N and Chen M (2014) Epigenetic silencing of dual oxidase 1 by promoter hypermethylation in human hepatocellular carcinoma. Am J Cancer Res 4:508-517.
• Liochev SI (2013) Reactive oxygen species and the free radical theory of aging. Free Radic Biol Med 60:1–4.
• Little AC, Sham D, Hristova M, Danyal K, Heppner DE, Bauer RA, Sipsey LM, Habibovic A and van der Vliet A (2016) DUOX1 silencing in lung cancer promotes EMT, cancer stem cell characteristics and invasive properties. Oncogenesis 5:e261.
• Little AC, Hristova M, van Lith L, Schiffers C, Dustin CM, Habibovic A, Danyal K, Heppner DE, Lin MJ, van der Velden J et al. (2019) Dysregulated redox regulation contributes to nuclear EGFR localization and pathogenicity in lung cancer. Sci Rep 9:4844.
• Liu Y, Fiskum G and Schubert D (2002) Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem 80:780-787.
• Louzada RA, Corre R, Ameziane-El-Hassani R, Hecht F, Cazarin J, Buffet C, Carvalho DP and Dupuy C (2018) Conformation of the N-terminal ectodomain elicits different effects on DUOX function: A potential impact on congenital hypothyroidism caused by a H₂O₂ production defect. Thyroid 28:1052-1062.
• Lu C, Qiu J, Huang P, Zou R, Hong J, Li B, Chen B and Yuan Y (2011) NADPH oxidase DUOX1 and DUOX2 but not NOX4 are independent predictors in hepatocellular carcinoma after hepatectomy. Tumor Bio 32:1173–1182.
• Luxen S, Belinsky SA and Knaus UG (2008) Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer. Cancer Res 68:1037-1045.
• Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P, Papaharalambus C, Lassègue B and Griendling KK (2009) Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res 105:249–259.
• Maier J, Van Steeg H, Van Oostrom C, Karger S, Paschke R and Krohn K (2006) Deoxyribonucleic acid damage and spontaneous mutagenesis in the thyroid gland of rats and mice. Endocrinology 147:3391–3397.
• Maruo Y, Takahashi H, Soeda I, Nishikura N, Matsui K, Ota Y, Mimura Y, Mori A, Sato H and Takeuchi Y (2008) Transient congenital hypothyroidism caused by biallelic mutations of the dual oxidase 2 gene in Japanese patients detected by a neonatal screening program. J Clin Endocrinol Metab 93:4261e4267.
• Meitzler JL and Ortiz de Montellano PR (2009) Caenorhabditis elegans and human dual oxidase 1 (DUOX1) “peroxidase” domains: Insights into HEME binding and catalytic activity. J Biol Chem 284:18634–18643.
• Meunier B, de Visser SP and Shaik S (2004) Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes. Chem Rev 104:3947-3980.
• Morand S, Chaaraoui M, Kaniewski J, Dème D, Ohayon R, Noel-Hudson MS, Virion A and Dupuy C (2003) Effect of iodide on nicotinamide adenine dinucleotide phosphate oxidase activity and DUOX2 protein expression in isolated porcine thyroid follicles. Endocrinology 144:1241–1248.
• Morand S, Ueyama T, Tsujibe S, Saito N, Korzeniowska A and Leto TL (2009) Duox maturation factors form cell surface complexes with Duox affecting the specificity of reactive oxygen species generation. FASEB J 23:1205–1218.
• Opitz N, Drummond GR, Selemidis S, Meurer S and Schmidt HHHW (2007) The `A’s and `O’s of NADPH oxidase regulation: A commentary on ``Subcellular localization and function of alternatively spliced Noxo1 isoforms’’. Free Radic Biol Med 42:175–179.
• Pettigrew CA, Clerkin JS and Cotter TG (2012) DUOX enzyme activity promotes AKT signalling in prostate cancer cells. Anti-cancer Res 32:5175-5181.
• Qi R, Zhou Y, Li X, Guo H, Gao L, Wu L, Wang Y and Gao Q (2016) DUOX2 Expression is increased in Barrett esophagus and cancerous tissues of stomach and colon. Gastroenterol Res Pract 2016:1835684.
• Rada B and Leto TL (2010) Characterization of hydrogen peroxide production by Duox in bronchial epithelial cells exposed to Pseudomonas aeruginosa. FEBS Lett 584:917–922.
• Rada B, Boudreau HE, Park JJ and Leto TL (2013) Histamine stimulates hydrogen peroxide production by bronchial epithelial cells via histamine H1 receptor and Duox. Am J Respir Cell Mol Biol 50:125-134.
• Rigutto S, Hoste C, Grasberger H, Milenkovic M, Communi D, Dumont JE, Corvilain B, Miot F and De Deken X (2009) Activation of dual oxidases Duox1 and Duox2: differential regulation mediated by camp-dependent protein kinase and protein kinase C-dependent phosphorylation. J Biol Chem 284:6725-6734.
• Roy K, Wu Y, Meitzler JL, Juhasz A, Liu H, Jiang G, Lu J, Antony S and Doroshow JH (2015) NADPH oxidases and cancer. Clin Sci (Lond) 128:863-875.
• Sabán-Ruiz J, Alonso-Pacho A, Fabregate-Fuente M and de la Puerta González-Quevedo C (2013) Xanthine oxidase inhibitor febuxostat as a novel agent postulated to act against vascular inflammation. Antiinflamm Antiallergy Agents Med Chem 12:94-99.
• Schwarzer C, Machen TE, Illek B and Fischer H (2004) NADPH oxidase-dependent acid production in airway epithelial cells. J Biol Chem 279:36454–36461.
• Sham D, Wesley UV, Hristova M and van der Vliet A (2013) ATP-mediated transactivation of the Epidermal Growth Factor Receptor in airway epithelial cells involves DUOX1-dependent oxidation of Src and ADAM17. PLoS One 8:e54391.
• Sies H and Jones DP (2007) Oxidative stress. In: Fink G (ed) Encyclopaedia of Stress. 2nd edition. Elsevier, Amsterdam, pp 45-48.
• Singh DK, Kumar D, Siddiqui Z, Basu SK, Kumar V and Rao KVS (2005) The strength of receptor signaling is centrally controlled through a cooperative loop between Ca2+ and an oxidant signal. Cell 121:281–293.
• Song Y, Ruf J, Lothaire P, Dequanter D, Andry G, Willemse E, Dumont JE, Van Sande J and De Deken X (2010) Association of duoxes with thyroid peroxidase and its regulation in thyrocytes. J Clin Endocrinol Metab 95:375-382.
• Takac I, Schröder K and Brandes RP (2012) The Nox family of NADPH oxidases: friend or foe of the vascular system? Curr Hypertens Rep 14:70-78.
• Ueno N, Takeya R, Miyano K, Kikuchi H and Sumimoto H (2005) The NADPH oxidase Nox3 constitutively produces superoxide in a p22phox-dependent manner: its regulation by oxidase organizers and activators. J Biol Chem 280:23328-23339.
• Ueyama T, Geiszt M and Leto TL (2006) Involvement of Rac1 in activation of multicomponent Nox1- and Nox3-based NADPH oxidases. Mol Cell Biol 26:2160-2174.
• van der Hoeven R, McCallum KC, Cruz MR and Garsin DA (2011) Ce-Duox1/BLI-3 generated reactive oxygen species trigger protective SKN-1 activity via p38 MAPK signaling during infection in C. elegans. PLoS Pathog 7:e1002453.
• Wang J, Shao M, Liu M, Peng P, Li L, Wu W, Wang L, Duan F, Zhang M, Song S et al. (2015) PKCα promotes generation of reactive oxygen species via DUOX2 in hepatocellular carcinoma. Biochem Biophys Res Commun 463:839-845.
• Wesley UV, Bove PF, Hristova M, McCarthy S and van der Vliet A (2007) Airway Epithelial Cell migration and wound repair by ATP-mediated activation of Dual Oxidase 1. J Biol Chem 282:3213–3220.
• Wong JL, Créton R and Wessel GM (2004) The oxidative burst at fertilization is dependent upon activation of the dual oxidase Udx1. Dev Cell 7:801–814.
• Wu Y, Antony S, Juhasz A, Lu J, Ge Y, Jiang G, Roy K and Doroshow JH (2011) Up-regulation and sustained activation of Stat1 are essential for interferon-gamma (IFN-gamma)-induced dual oxidase 2 (Duox2) and dual oxidase A2 (DuoxA2) expression in human pancreatic cancer cell lines. J Biol Chem 286:12245-12256.
• Wu Y, Antony S, Hewitt SM, Jiang G, Yang SX, Meitzler JL, Juhasz A, Lu J, Liu H, Doroshow JH et al. (2013a) Functional activity and tumor-specific expression of dual oxidase 2 in pancreatic cancer cells and human malignancies characterized with a novel monoclonal antibody. Int J Oncol 42:1229-1238.
• Wu Y, Lu J, Antony S, Juhasz A, Liu H, Jiang G, Meitzler JL, Hollingshead M, Haines DC, Butcher D et al. (2013b) Activation of TLR4 is required for the synergistic induction of dual oxidase 2 and dual oxidase A2 by INF-γ and lipopoly-saccharide in human pancreatic cancer cell lines. J Immunol 190:1859-1872.
• Wu Y, Meitzler JL, Antony S, Juhasz A, Lu J, Jiang G, Liu H, Hollingshead M, Haines DC, Butcher D et al. (2016) Dual oxidase 2 and pancreatic adenocarcinoma: INF-γ-mediated dual oxidase 2 overexpression results in H₂O₂-induced, ERK-associated up-regulation of HIF-1α and VEGF-A. Oncotarget 7:68412-68433.
• You X, Ma M, Hou G, Hu Y and Shi X (2018) Gene expression and prognosis of NOX family members in gastric cancer. Onco Targets Ther 11:3065-3074.
• Zamproni I, Grasberger H, Cortinovis F, Vigone MC, Chiumello G, Mora S, Onigata K, Fugazzola L, Refetoff S, Persani L et al. (2008) Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism. J Clin Endocrinol Metab 93:605e610.

Edited by

Associate Editor: Nadja Souza Pinto

Publication Dates

• Publication in this collection
  20 May 2020
• Date of issue
  2020

History

• Received
  20 Mar 2019
• Accepted
  24 Jan 2020